Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course

Núria Setó-Salvia, Javier Pagonabarraga, Henry Houlden, Berta Pascual-Sedano, Oriol Dols-Icardo, Arianna Tucci, Coro Paisán-Ruiz, Antonia Campolongo, Sofía Antón-Aguirre, Inés Martín, Laia Muñoz, Enric Bufill, Lluïsa Vilageliu, Daniel Grinberg, Mónica Cozar, Rafael Blesa, Alberto Lleó, John Hardy, Jaime Kulisevsky, Jordi Clarimón

Research output: Contribution to journalArticleResearchpeer-review

107 Citations (Scopus)


Mutations in the glucocerebrosidase gene are associated with Parkinson's disease and Lewy body dementia. However, whether these alterations have any effect on the clinical course of Parkinson's disease is not clear. The glucocerebrosidase coding region was fully sequenced in 225 Parkinson's disease patients, 17 pathologically confirmed Lewy body dementia patients, and 186 controls from Spain. Twenty-two Parkinson's disease patients (9.8%) and 2 Lewy body dementia patients (11.8%) carried mutations in the glucocerebrosidase gene, compared with only 1 control (0.5%); P = .016 and P = .021 for Parkinson's disease and Lewy body dementia, respectively. The N370S and the L444P mutations represented 50% of the alterations. Two novel variants, L144V and S488T, and 7 previously described alterations were also found. Alterations in glucocerebrosidase were associated with a significant risk of dementia during the clinical course of Parkinson's disease (age at onset, years of evolution, and sex-adjusted odds ratio, 5.8; P = .001). Mutation carriers did not show worse motor symptoms, had good response to L-dopa, and tended to present the intermediate parkinsonian phenotype. Our findings suggest that mutations in the glucocerebrosidase gene not only increase the risk of both Parkinson's disease and Lewy body dementia but also strongly influence the course of Parkinson's disease with respect to the appearance of dementia. © 2011 Movement Disorder Society.
Original languageEnglish
Pages (from-to)393-399
JournalMovement Disorders
Issue number3
Publication statusPublished - 1 Mar 2012


  • Dementia
  • Genetics
  • Glucocerebrosidase
  • Lewy body disease
  • Parkinson's disease


Dive into the research topics of 'Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course'. Together they form a unique fingerprint.

Cite this